Data updated: Mar 10, 2026
NALBUPHINE HYDROCHLORIDE
NALBUPHINE HYDROCHLORIDE
Approved 1986-07-02
7
Indications
--
Phase 3 Trials
39
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1986-07-02
- Routes
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INJECTION
- Dosage Forms
- SOLUTION, INJECTABLE
NALBUPHINE HYDROCHLORIDE Approval History
Loading approval history...
What NALBUPHINE HYDROCHLORIDE Treats
7 FDA approvalsOriginally approved for its first indication in 1986 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (Jul 1986)
- • Approved indication (Feb 1989)
- • Approved indication (Mar 1993)
- • Approved indication (Mar 1998)
- • Approved indication (Jan 2019)
- • Approved indication (Feb 2019)
- • Approved indication (Sep 2024)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NALBUPHINE HYDROCHLORIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.